The novel approach of the medication represents a significant advance in the care of the condition. Different to existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide421212.bloggazzo.com/40757092/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment